David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 260 shares at $23.04 ($6K) on 2025-04-21, disclosed to the SEC on 2025-04-23.
Seasonal sale ($6k) by SVP, Life Sciences — this insider has traded PHR in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |